Nephros, Inc.
NEPH
$3.42
-$0.13-3.66%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 26.02% | 10.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.02% | 10.01% | |||
| Cost of Revenue | 23.51% | 1.90% | |||
| Gross Profit | 27.43% | 15.17% | |||
| SG&A Expenses | 20.41% | 8.77% | |||
| Depreciation & Amortization | 14.71% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.33% | 7.28% | |||
| Operating Income | 78.55% | 53.88% | |||
| Income Before Tax | 53.30% | 98.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 59.89% | 90.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.89% | 90.71% | |||
| EBIT | 78.55% | 53.88% | |||
| EBITDA | 72.16% | 47.28% | |||
| EPS Basic | 58.91% | 90.23% | |||
| Normalized Basic EPS | 52.31% | 100.00% | |||
| EPS Diluted | 51.06% | 90.23% | |||
| Normalized Diluted EPS | 52.31% | 100.00% | |||
| Average Basic Shares Outstanding | 0.53% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.57% | -0.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||